Sigma-Aldrich stockholders approve acquisition by Merck KGaA

December 11, 2014 | Thursday | News | By BioSpectrum Bureau

Sigma-Aldrich stockholders approve acquisition by Merck KGaA

(Photo Courtesy: www.tryitlocal.com)

(Photo Courtesy: www.tryitlocal.com)

Sigma-Aldrich Corp's stockholders voted to adopt the previously announced merger agreement providing for the acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, at a special meeting of stockholders.

Sigma-Aldrich stockholders also approved, on an advisory, non-binding basis, compensation that may become payable to named executive officers as a result of the acquisition.

As previously announced, on September 22, 2014, the board of directors for Sigma-Aldrich approved the merger agreement under which Merck KGaA will acquire Sigma-Aldrich for $140.00 per share in cash.

The transaction, which is expected to close in mid-2015, remains subject to the satisfaction of the closing conditions set forth in the merger agreement, including regulatory approvals.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy